TY - JOUR AU - Perez-Belmonte, Luis M AU - Torres-Peña, Jose David AU - Lopez-Carmona, Maria D AU - Ayala-Gutierrez, M Mar AU - Fuentes-Jimenez, Francisco AU - Huerta, Lucia Jorge AU - Muñoz, Jaime Alonso AU - Rubio-Rivas, Manuel AU - Madrazo, Manel AU - Garcia, Marcos Guzman AU - Montes, Beatriz Vicente AU - Sola, Joaquim Fernandez AU - Ena, Javier AU - Ferrer, Ruth Gonzalez AU - Perez, Carmen Mella AU - Ripper, Carlos Jorge AU - Lecumberri, Jose Javier Napal AU - Acedo, Iris El Attar AU - Canteli, Susana Plaza AU - Cosio, Sara Fuente AU - Martinez, Francisco Amoros AU - Rodriguez, Begoña Cortes AU - Perez-Martinez, Pablo AU - Ramos-Rincon, Jose Manuel AU - Gómez-Huelgas, Ricardo PY - 2020 DO - 10.1186/s12916-020-01832-2 UR - http://hdl.handle.net/10668/16601 T2 - BMC medicine AB - Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital death and each routine at-home glucose-lowering drug both individually and in combination... LA - en PB - BioMed Central KW - Coronavirus disease 2019 KW - Glucose-lowering drug KW - Type 2 diabetes mellitus KW - Aged KW - Aged, 80 and over KW - Betacoronavirus KW - COVID-19 KW - Cohort Studies KW - Coronavirus Infections KW - Diabetes Mellitus, Type 2 KW - Dipeptidyl-Peptidase IV Inhibitors KW - Drug Therapy, Combination KW - Female KW - Hospital Mortality KW - Hospitalization KW - Humans KW - Hypoglycemic Agents KW - Insulin KW - Intensive Care Units KW - Length of Stay KW - Logistic Models KW - Male KW - Metformin KW - Noninvasive Ventilation KW - Pandemics KW - Pneumonia, Viral KW - Prospective Studies KW - Respiration, Artificial KW - SARS-CoV-2 KW - Sodium-Glucose Transporter 2 Inhibitors KW - Spain TI - Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study. TY - research article VL - 18 ER -